LAMIVUDINE AND ZIDOVUDINE

7705 reported adverse events

Drug classes: Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]

These side effects are most commonly reported by patients taking LAMIVUDINE AND ZIDOVUDINE:

# Side effect Count
0 DRUG EXPOSURE DURING PREGNANCY 1147
1 FOETAL EXPOSURE DURING PREGNANCY 720
2 PAIN 601
3 ANXIETY 568
4 EMOTIONAL DISTRESS 557
5 ANHEDONIA 504
6 ANAEMIA 453
7 ABORTION SPONTANEOUS 443
8 MATERNAL EXPOSURE DURING PREGNANCY 381
9 PREMATURE BABY 363
See all common reactions for LAMIVUDINE AND ZIDOVUDINE

LAMIVUDINE AND ZIDOVUDINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BONE DEMINERALISATION 96 0.0907
1 POLYDACTYLY 75 0.0647
2 TRISOMY 21 79 0.0627
3 STILLBIRTH 278 0.0575
4 LIPODYSTROPHY ACQUIRED 120 0.0565
5 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 61 0.0564
6 INTRA-UTERINE DEATH 71 0.0442
7 DRUG EXPOSURE DURING PREGNANCY 1147 0.0337
8 PREMATURE RUPTURE OF MEMBRANES 67 0.0278
9 VIRAL MUTATION IDENTIFIED 100 0.0271
See all enriched reactions for LAMIVUDINE AND ZIDOVUDINE